nomifensine has been researched along with Cognition Disorders in 6 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Excerpt | Relevance | Reference |
---|---|---|
"The nomifensine-treated depressed patients showed significant improvement over the placebo depressed patients early in and throughout treatment." | 2.65 | Nomifensine in geriatric inpatients: a placebo-controlled study. ( Jansen, W; Siegfried, K, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nikiforuk, A | 1 |
Popik, P | 1 |
Guzmán-Ramos, K | 1 |
Moreno-Castilla, P | 1 |
Castro-Cruz, M | 1 |
McGaugh, JL | 1 |
Martínez-Coria, H | 1 |
LaFerla, FM | 1 |
Bermúdez-Rattoni, F | 1 |
Bain, JN | 1 |
Prendergast, MA | 1 |
Terry, AV | 1 |
Arneric, SP | 1 |
Smith, MA | 1 |
Buccafusco, JJ | 1 |
Jansen, W | 1 |
Siegfried, K | 2 |
Thompson, PJ | 1 |
Trimble, MR | 1 |
1 trial available for nomifensine and Cognition Disorders
Article | Year |
---|---|
Nomifensine in geriatric inpatients: a placebo-controlled study.
Topics: Aged; Clinical Trials as Topic; Cognition Disorders; Depressive Disorder; Double-Blind Method; Fatig | 1984 |
5 other studies available for nomifensine and Cognition Disorders
Article | Year |
---|---|
Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants.
Topics: Animals; Antidepressive Agents; Attention; Behavior, Animal; Citalopram; Cognition Disorders; Desipr | 2011 |
Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brai | 2012 |
Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential.
Topics: Animals; Atomoxetine Hydrochloride; Attention; Caffeine; Cognition; Cognition Disorders; Color Perce | 2003 |
Non-MAOI antidepressant drugs and cognitive functions: a review.
Topics: Amitriptyline; Antidepressive Agents; Cognition; Cognition Disorders; Depressive Disorder; Dose-Resp | 1982 |
Cognitive symptoms in late-life depression and their treatment.
Topics: Age Factors; Aged; Cognition Disorders; Depressive Disorder; Humans; Nomifensine | 1985 |